# Replimune Group, Inc.: Form 8-K, filed Sep 10, 2019

- Company: [Replimune Group, Inc.](/companies/repl.md) (CIK 1737953)
- Form: 8-K
- Filed: 2019-09-10
- Accepted by EDGAR: Sep 10, 2019, 16:00 ET
- Period: 2019-09-04
- Accession: 0001104659-19-049527
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1737953/000110465919049527/a19-18390_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737953/000110465919049527/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737953/000110465919049527/a19-18390_18k.htm

Filed Sep 10, 2019.
Source: SEC EDGAR, the filing index for accession 0001104659-19-049527. Last ingested by Listed: Nov 7, 2026, 12:41 ET. No prices; not investment advice.
